Fondaparinux Sodium
Fondaparinux Sodium is a pharmaceutical drug with 17 clinical trials. Currently 1 active trials ongoing. Historical success rate of 93.3%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
14 of 16 finished
12.5%
2 ended early
1
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
Clinical Trials (17)
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)
Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
Hemorrhage Risk Prescribed Arixtra
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17